All News | FDA

Advertising & Promotion

Aug 1, 2022
FTC Opens Endorsement and Testimonial Guide Revisions for Public Comment
Jul 29, 2022
Device Maker Settles Kickback Allegations
Jul 25, 2022
FDA Issues Warning Letter Over Compounded Drug Claims
Jul 15, 2022
House Bill Would Set Deadline for FDA’s Final Rule on DTC Prescription Drug Ads
Jul 8, 2022
FTC Consent Order Bans Two Companies and Owner from Advertising or Selling Dietary Supplements
Jul 1, 2022
Release of FDA’s Final Rule on DTC Drug Ads Pushed to May 2023
Jun 27, 2022
Oregon Issues Permanent Rules for Drug Sales Rep Licensing
Jun 20, 2022
FTC Enforcement To Focus on PBM Rebates and Fees
Jun 10, 2022
Washington Supreme Court: Direct-to-Consumer Advertising Does Not Dilute Learned Intermediary Doctrine
Jun 7, 2022
Third OPDP Untitled Letter of 2022 Cites Risk Presentation, Efficacy Claims

Good Clinical Practice

Sep 18, 2022
New Draft Guidance on Clinical Pharmacology Considerations for Pediatric Studies Expands 2014 Guidance
Sep 12, 2022
Work Group Issues Recommendations To Improve Communication with Subjects When Trials End Early
Sep 6, 2022
ORI Opens 'Brainstorming Process' for Research Misconduct Rule Revision
Aug 26, 2022
FDA Provides Additional Answers on Charging for Investigational Drugs
Aug 19, 2022
OIG Audit Finds NIH-funded Trials Not Posting Results
Aug 12, 2022
SACHRP Asks for More Clarity in HHS Single IRB Guidance
Aug 1, 2022
SACHRP Recommends New Definitions of ‘Engagement’ and ‘Support’
Jul 29, 2022
Sponsor-investigator Receives FDA Warning Letter; BRANY Gets Determination Letter
Jul 24, 2022
Two More Clinical Trial Staff Plead Guilty to Falsifying Data
Jul 20, 2022
Abbott Funds Clinical Trial Diversity Program

U.S. Food Labeling

Sep 1,2021
Congress Again Moves To Mandate Updates to Food Labeling
Aug 19,2021
FDA Rejects NDIs for CBD Products Intended To Be Marketed as Dietary Supplements
Aug 4,2021
Courts in Three Separate Product Actions Side With Trader Joe’s
Jul 22,2021
FDA Releases Preview of Planned Upcoming Labeling Guidances
Jul 8,2021
USDA Commits to Wholesale Review of ‘Product of USA’ Labeling
Jun 23,2021
FDA Updates Standard of Identity for Yogurt Products
Jun 15,2021
NOSB Will Meet in October
Jun 9,2021
Supplement Firm Asks Court To Dismiss Class Action
May 26,2021
AMS Releases Results of 2020 NOP Enforcement Activity
May 13,2021
FDA Undertakes Research on ‘Healthy’ Symbols as Prelude to Regulations

FDA Regulation & Enforcement

Jan 31, 2025
Sen. Sanders To Reintroduce Food Warning Label Legislation
Jan 29, 2025
Pfizer To Pay Nearly $60 Million To Resolve Kickback Allegations Arising From Subsidiary’s Speaker Programs
Jan 29, 2025
Court Dismisses False Claims Allegations Against IVD Device Maker, Citing Rule 9(b) Particularity
Jan 28, 2025
Congress Reintroduces Bills To Require Price Disclosures in DTC Ads
Jan 24, 2025
FDA Provides Draft Guidance on Labeling Plant-Based Alternative Foods
Jan 22, 2025
Providing Free Drug That Has Only Limited Coverage Will Not Trigger Sanctions, HHS OIG Says
Jan 17, 2025
FDA Proposes Front-of-Package Label for Food Products
Jan 15, 2025
OIG: Patient Assistance for Autologous T-Cell Treatment Would Not Trigger Administrative Sanctions
Jan 15, 2025
Former McKinsey Partner Pleads Guilty to Obstruction Charge Tied to Firm’s Advice to Purdue Pharma
Jan 10, 2025
FDA Issues ‘Safe Harbor’ Guidance on Providing SIUU Info to Health Care Providers

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.